These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 35141154)

  • 21. Interpretation of p16(INK4a) /Ki-67 dual immunostaining for the triage of human papillomavirus-positive women by experts and nonexperts in cervical cytology.
    Allia E; Ronco G; Coccia A; Luparia P; Macrì L; Fiorito C; Maletta F; Deambrogio C; Tunesi S; De Marco L; Gillio-Tos A; Sapino A; Ghiringhello B
    Cancer Cytopathol; 2015 Apr; 123(4):212-8. PubMed ID: 25534957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Value of MicroRNA-375 Detection for Triaging Primary Human Papillomavirus Positive Women: A Cross-Sectional Study in a General Population.
    Wu Q; Wang L; Zhao X; Tian Q; Wang F; Sima N; Qiu L; Lu W; Xie X; Wang X; Cheng X
    Front Oncol; 2021; 11():771053. PubMed ID: 34778090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P16INK4a/ki67 Immunocytochemistry in Improving the Predictive Value for High Grade Cervical Intraepithelial (≥CIN2) Neoplasia in Pap Smear.
    Kumar GV; Prabhu AJ; Sebastian A; Raghavendran ; Abraham P; Peedicayil A
    J Cytol; 2021; 38(4):180-185. PubMed ID: 35002109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating the Performance of p16
    Song F; Du H; Xiao A; Wang C; Huang X; Yan P; Liu Z; Qu X; Belinson JL; Wu R
    Cancer Manag Res; 2020; 12():9067-9075. PubMed ID: 33061601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Performance of Immunocytochemistry Staining as Triaging Tests for High-Risk HPV-Positive Women: A 24-Month Prospective Study.
    Li YC; Zhao YQ; Li TY; Chen W; Liao GD; Wang HR; Lei HK; Guo Y; Zhou Q
    J Oncol; 2020; 2020():6878761. PubMed ID: 32565806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triage Strategies for Non-16/Non-18 HPV-Positive Women in Primary HPV-Based Cervical Cancer Screening: p16/Ki67 Dual Stain vs. Cytology.
    Mazurec K; Trzeszcz M; Mazurec M; Streb J; Halon A; Jach R
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of CINtec PLUS® testing as an adjunctive test in ASC-US diagnosed SurePath® preparations.
    Edgerton N; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2013 Jan; 41(1):35-40. PubMed ID: 21710645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic and diagnostic validity of p16/Ki-67, HPV E6/E7 mRNA, and HPV DNA in women with ASCUS: a follow-up study.
    Ren C; Zhu Y; Yang L; Zhang X; Liu L; Wang Z; Jiang D
    Virol J; 2019 Nov; 16(1):143. PubMed ID: 31752941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The p16/ki-67 assay is a safe, effective and rapid approach to triage women with mild cervical lesions.
    Magkana M; Mentzelopoulou P; Magkana E; Pampanos A; Daskalakis G; Domali E; Rodolakis A; Pappa K
    PLoS One; 2021; 16(6):e0253045. PubMed ID: 34115809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p16(INK4a)/Ki-67 dual stain cytology for cervical cancer screening in Thika district, Kenya.
    Ngugi CW; Schmidt D; Wanyoro K; Boga H; Wanzala P; Muigai A; Mbithi J; von Knebel Doeberitz M; Reuschenbach M
    Infect Agent Cancer; 2015; 10():25. PubMed ID: 26265934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of p16/Ki67 immunostaining in the triage of women referred to colposcopy.
    Ordi J; Sagasta A; Munmany M; Rodríguez-Carunchio L; Torné A; del Pino M
    Cancer Cytopathol; 2014 Mar; 122(3):227-35. PubMed ID: 24757722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the clinical performance of p16/Ki-67 dual-staining cytology for cervical lesion detection in premenopausal and postmenopausal Chinese women.
    Dai Y; Chen T; Li X; Zhang C; Li T; Zhao Y; Wang Y; Chen S; Yu L; Jiang M; Wu Z; Yang J; Chen W
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10645-10658. PubMed ID: 37302113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPV genotype-specific distribution and attributable risk in cervical intraepithelial neoplasia in a referral population with a history of LSIL.
    Ratnam S; Jang D; Alaghehbandan R; Gilbert L; Xu Y; Wang W; Andrews P; Green A; Speicher DJ; Chernesky M
    Cancer Biomark; 2023; 38(4):433-442. PubMed ID: 37980645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intra- and inter-observer reproducibility of CINtec
    McMenamin M; McKenna M; McDowell A; Dawson C; McKenna R
    Cytopathology; 2017 Aug; 28(4):284-290. PubMed ID: 28685883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages.
    Schmitz M; Eichelkraut K; Schmidt D; Zeiser I; Hilal Z; Tettenborn Z; Hansel A; Ikenberg H
    BMC Cancer; 2018 Dec; 18(1):1197. PubMed ID: 30509219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of p16/Ki67 double immunocytochemistry for detection of cervical adenocarcinoma.
    Ryu A; Honma K; Shingetsu A; Tanada S; Yamamoto T; Nagata S; Kamiura S; Yamasaki T; Ohue M; Matsuura N
    Cancer Cytopathol; 2022 Dec; 130(12):983-992. PubMed ID: 35976043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancing Cervical Cancer Screening: Review of p16/Ki-67 Dual Staining as a Promising Triage Strategy.
    Ouh YT; Kim HY; Yi KW; Lee NW; Kim HJ; Min KJ
    Diagnostics (Basel); 2024 Feb; 14(4):. PubMed ID: 38396493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunocytochemical expression of Ki-67/p16 in normal, atypical, and neoplastic cells in urine cytology using BD SurePath™ as preparation method.
    Østbye KM; Pedersen MK; Sauer T
    Cytojournal; 2019; 16():26. PubMed ID: 31897084
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.